Will This Pharmaceutical Company Keep Hitting All-Time Highs?
Shire's stock has soared over the past year on strong sales of ADHD treatments. Will the company's simple growth strategy keep propelling this stock higher?
3 Catalysts Biocryst Investors Need to Watch
Can Biocryst rise even higher after gaining nearly 300% this year? Here are 3 important catalysts to watch.